Glycosylation characteristics of colorectal cancer

S Holst, M Wuhrer, Y Rombouts - Advances in cancer research, 2015 - Elsevier
Glycans on proteins and lipids are known to alter with malignant transformation. The study of
these may contribute to the discovery of biomarkers and treatment targets as well as …

Fucosylation in cancer biology and its clinical applications

M Shan, D Yang, H Dou, L Zhang - Progress in molecular biology and …, 2019 - Elsevier
Fucosylation is the process of transferring fucose from GDP-fucose to their substrates, which
includes certain proteins, N-and O-linked glycans in glycoprotein or glycolipids, by …

Global map** of glycosylation pathways in human-derived cells

YF Huang, K Aoki, S Akase, M Ishihara, YS Liu… - Developmental cell, 2021 - cell.com
Glycans are one of the fundamental classes of macromolecules and are involved in a broad
range of biological phenomena. A large variety of glycan structures can be synthesized …

O-glycan recognition and function in mice and human cancers

GE Cervoni, JJ Cheng, KA Stackhouse… - Biochemical …, 2020 - portlandpress.com
Protein glycosylation represents a nearly ubiquitous post-translational modification, and
altered glycosylation can result in clinically significant pathological consequences. Here we …

Drug resistance related to aberrant glycosylation in colorectal cancer

N Very, T Lefebvre, I El Yazidi-Belkoura - Oncotarget, 2017 - pmc.ncbi.nlm.nih.gov
Colorectal cancer (CRC) is the fourth leading cause of cancer-related deaths in the world.
Drug resistance of tumour cells remains the main challenge toward curative treatments …

Therapeutic potential of fucosyltransferases in cancer and recent development of targeted inhibitors

Y Lv, Z Zhang, S Tian, W Wang, H Li - Drug Discovery Today, 2023 - Elsevier
Highlights•Aberrant fucosylation is a signature of malignant cell transformation and
modulates the occurrence and development of cancer.•Targeting fucosyltransferases (FUTs) …

Comparative N-Glycan Profiling of Colorectal Cancer Cell Lines Reveals Unique Bisecting GlcNAc and α-2,3-Linked Sialic Acid Determinants Are Associated with …

MK Sethi, M Thaysen-Andersen, JT Smith… - Journal of proteome …, 2014 - ACS Publications
Advances in colorectal cancer (CRC) diagnosis will be enhanced by development of more
sensitive and reliable methods for early detection of the disease when treatment is more …

High diversity of glycosphingolipid glycans of colorectal cancer cell lines reflects the cellular differentiation phenotype

D Wang, K Madunić, T Zhang, OA Mayboroda… - Molecular & Cellular …, 2022 - ASBMB
Colorectal cancer (CRC)–associated changes of protein glycosylation have been widely
studied. In contrast, the expression of glycosphingolipid (GSL) patterns in CRC has, hitherto …

Glycomic approaches for the discovery of targets in gastrointestinal cancer

S Mereiter, M Balmaña, J Gomes, A Magalhães… - Frontiers in …, 2016 - frontiersin.org
Gastrointestinal (GI) cancer is the most common group of malignancies and many of its types
are among the most deadly. Various glycoconjugates have been used in clinical practice as …

Alteration of N-glycans and expression of their related glycogenes in the epithelial-mesenchymal transition of HCV29 bladder epithelial cells

J Guo, X Li, Z Tan, W Lu, G Yang, F Guan - Molecules, 2014 - mdpi.com
The epithelial-mesenchymal transition (EMT) is an essential step in the proliferation and
metastasis of solid tumor cells, and glycosylation plays a crucial role in the EMT process …